PropheX Information

Over 90% of drugs never reach approval. Each failure is a tragedy, costing decades of work and billions in capital. Yet most decision makers still rely on the same analyst reports and consensus views. We believe biology should decide the outcome. PropheX works with our partners to make real drugs and collect real biological data. Data from human tissue: living liver, heart, brain, kidney, and more. Drug candidates are physically tested on these microtissues to collect a multi-modal dataset that we use to score the risks with machine learning across safety, efficacy, PK/PD, manufacturing, and more. The result: a data-driven prediction of how a trial will unfold, before the market sees it coming. What once took 2 to 5 years and millions of dollars, we can simulate in 2 to 6 months, at a fraction of the cost, on automated infrastructure that delivers reproducible results.